Tandospirone is a novel non-benzodiazepine compound possessing po tent anxiolytic properties in a water lick conflict paradigm in rats and a high affinity
It has been long suggested that the central serotonin (5-HT) system may be involved in the modulation of anxiety (1) . The recent de velopment of compounds that interact in a specific manner with part of the 5-HT system has provided evidence that there are several subtypes of central 5-HT receptors: 5-HTI, 5 HT2, 5-HT3 and 5-HT4 receptors (2, 3) , and these compounds have provided a means to elucidate the role of 5-HT in anxiety in more detail. Particularly, recent attention has been focused on 5-HTIA receptors, a subtype of 5 HT, receptors, because of their high densities in the hippocampus and other parts of the lim bic system that may be involved in the control of anxiety states (4) . We previously reported that tandospirone (3aa,4l,7/9,7aa-hexahydro 2 -(4-(4-(2-pyrimidinyl)-1-piperazinyl)-butyl) 4,7 methano-lH-isoindole-1,3(2H)-dione dihydro gen citrate) is a non-benzodiazepine com pound possessing both potent anxiolytic prop erties in animal models (5) and a high affinity for 5-HT1A receptors (6) . Therefore, this com pound may be useful not only as a new thera peutic drug for treating anxiety, but also a valuable tool for basic research on the role of 5-HT in anxiety.
In the meantime, a number of animal mod els of anxiety have been developed to predict the clinical potencies of drugs (7) . The Geller Seifter conflict test (8) is one of the most reli able tests for anxiolytic activity, because there is a good correlation between the minimum effective doses of anxiolytics in this test and their clinical doses (9) . In the present study, we evaluated the anxiolytic activity of tando spirone in rats with a modified Geller-Seifter conflict test, comparing it with that of diaz epam. Furthermore, we also studied both the effect of a benzodiazepine antagonist on the anticonflict action of tandospirone and the anxiolytic activity of 8-hydroxy-2-(di-n-propyl amino)tetralin (8-OH-DPAT), a selective 5 HT1A agonist.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats (270-320g) were kept on a controlled light-dark cycle (lights on 0800-2000 hours) in a room with constant temperature (24 ± 1°C) and humidity (55 ± 5%). These animals were gradually re duced to 80% of normal body weight and then given training as described below. They were maintained at this level (approximately 80 85% of the free-feeding weight) by limited feeding after each experimental session.
Apparatus
A conventional Skinner box (30 X 30 X 27.5 cm; Medical Agent Co., Ltd.) containing a response lever, an automatic feeder for the delivery of a solid food reward (50 mg), an electrified-grid floor, and a small speaker and a red lamp for the presentation of auditory and visual stimulus, respectively, was used. This box was enclosed by a sound-resistant, ventilated chamber, and this chamber was set in a sound-resistant room. Programming and recording of the experiment were automated, and the intensity of foot-shock punishment was adjusted for each rat during training to achieve an optimal degree of suppression (range: 0.5 -1.3 mA, 0.5 sec duration).
Procedure
The animals were first trained to respond on a fixed-ratio schedule of 20 lever-press re sponses for each food reinforcement (FR20).
After stable FR20 performance was de veloped, nonaversive tone (2 kHz, 85 dB) and light (14 lux) stimuli of 3-min duration were activated every 15 min during the 60-min ex perimental session. These stimuli signaled that every lever response would be reinforced with food, in contrast to the no-stimulus (un punished) periods when every 20th response was food reinforced. Conflicts were then in duced by punishing all lever responses in the presence of the stimuli (the punished periods) with a scrambled electric shock through the grid floor: thus, the rats were simultaneously rewarded with food and punished with shock for every lever response made in the 3-min punished periods. The daily 60-min ex perimental sessions consisted of four 12-min unpunished periods and four 3-min punished periods; and they were conducted at the same time, Monday through Friday, for each rat. The rats that exhibited stable rates of un punished and punished responding after train ing for about 4 weeks were used for the drug studies.
Analysis of result
Unpunished responding was expressed as a percentage of control responses that were made in the unpunished periods on the day before the drug injection for each individual rat. Punished responding was expressed as the number of responses made in the punished periods (12 min). All results are represented as the mean values ± S.E.M. obtained from five to ten rats. Drug effects were assessed statistically by comparing the responding after the administration of drugs to the responding after the administration of vehicle using Dun nett's test or Duncan's test.
Drugs
Tandospirone, 8-OH-DPAT HBr, diazepam and Ro-15-1788 were synthesized at the Sumi tomo Pharmaceuticals Co., Ltd. Diazepam and Ro-15-1788 were suspended in an aqueous solution containing 0.5% methyl cellulose, and the other drugs were dissolved in 0.9% sterile saline. Injections were given intraperitoneally (i.p.), orally (p.o.) or subcutaneously (s.c.) in a constant volume of 5.0 ml/kg. Ro-15-1788 and the other drugs were administered 10 min and immediately, respectively, prior to testing. 
RESULTS
The introduction of punishment with electric shock markedly reduced the rates of respond ing during the punished periods. The mean rates of lever pressing in rats treated with the vehicle (N = 45) were 3985.5 ± 108.0/session (48 min) and 1.3 ± 0.1/session (12 min) for the unpunished periods and the punished periods, respectively.
The effects of tandospirone on lever press ing are shown in Fig. 1 . Tandospirone when administered i.p. produced significant in creases in punished responding at doses of 1.25, 2.5 and 5.0 mg/kg. Unpunished respond ing remained stable at doses of up to 1.25 mg/kg, but was significantly decreased at doses of 2.5 and 5.0 mg/kg in a dose-depend ent manner. Following oral administration, tandospirone also produced a significant in crease in punished responding at 20 mg/kg in spite of a significant decrease in unpunished responding. Figure 2 shows the effects of i.p. administration of diazepam on lever pressing. Likewise, diazepam also produced significant increases in punished responding at doses of 2.5 and 5.0 mg/kg, although it decreased un punished responding at 5.0 mg/kg. The mini mum effective dose of diazepam was slightly higher than that of tandospirone. Figure 3 shows the effects of Ro-15-1788, a benzodiazepine antagonist, on the anticonflict action of tandospirone and diazepam. Ro-15 1788 (10 mg/kg, i.p.) significantly reduced punished responding that normally occurs af ter diazepam (2.5 mg/kg, i.p.), without affect ing unpunished responding. In contrast, this dose of Ro-15-1788 failed to produce any sig nificant changes in punished responding en hanced by tandospirone. Figure 4 shows the effect of s.c.-administra tion of 8-OH-DPAT, a 5-HT1A receptor selec tive agonist, on lever pressing. Punished re sponding showed an upward trend after 0.05 mg/kg of 8-OH-DPAT, but this change was not significant. 8-OH-DPAT at 0.1 mg/kg, however, significantly increased punished re sponding without affecting unpunished re sponding. 
DISCUSSION
In the present study, we found that tando spirone, whether administered i.p. or p.o., pro duced significant increases in punished re sponding in a modified Geller-Seifter conflict paradigm (main modifications are changing the food reward from a liquid (sweetened con densed milk) to a solid (a pellet of food) and changing the schedule to include an un punished period from VI-2 min to FR-20) in rats. We also observed that the effect of diaz epam in this test was similar to that of tandos pirone. These results indicate that tandospir one as well as diazepam can show anticonflict actions in this conflict procedure. Moreover, good agreement of the minimum effective dose of tandospirone in this test with that of diazepam suggests that tandospirone might be as effective in the treatment of anxiety as di azepam. On the other hand, tandospirone as well as diazepam significantly reduced un punished responding. Lack of muscle relaxant action (5), which diazepam markedly shows, suggests that the mechanism of the decrease in unpunished responding by tandospirone is different from that by diazepam. Since tandos pirone produces 5-HT behavioral syndromes such as flat body posture in rats (10) , this ac tion of tandospirone may be related to the de crease in unpunished responding.
Recently, there have been many reports evaluating the anxiolytic activities of azapir ones, such as buspirone and tandospirone, in conventional animal models of anxiety, but the data were not consistently positive (11) . For example, in rat conflict tests, which are the most widely used animal behavioral para digms for recognizing potential anxiolytic drug activity, some groups, including our own, were able to demonstrate anticonflict activities of azapirones (5, (12) (13) (14) , while others failed to find any positive effects (15) (16) (17) . Moreover, in the former cases, the efficacies of azapir ones were substantially lower than those of benzodiazepines. In the present study, we also found that the magnitude of the tandospirone induced increase in punished responding was considerably less than that observed with di azepam, although the potency (i.e., the mini mum effective dose) of tandospirone was high er than that of diazepam. Conventional con flict tests have been mainly developed in stud ies of benzodizepines. Since azapirones differ from benzodiazepines not only in chemical structure but also in pharmacological prop erties (5, 18) , these tests might be less sensi tive to non-benzodiazepines such as azapir ones. Therefore, the fine differences in test conditions (e.g., shock intensity, degree of de privation and conflict schedule conditions) may have led to the inconsistent results pre viously described.
Tandospirone has no affinity for the benzodiazepine/GABA receptor complex that is thought to mediate the anxiolytic effect of benzodiazepines (6) . As was expected from that, Ro-15-1788, a benzodiazepine antagonist, showed no effect on the anticonflict action of tandospirone, though the same dose of Ro-15 1788 completely inhibited that of diazepam. This result suggests that benzodiazepine recep tors do not participate in the mechanism of ac tion of tandospirone. We previously reported that tandospirone binds selectively to central 5-HT1A receptors with a high affinity in bind ing studies using either membranes or sections of rat brain as receptor preparations of the CNS (6, (19) (20) (21) . All other azapirones that are clinically effective also bind selectively to 5 HT1A receptors (22) . Moreover, we have also demonstrated that tandospirone acts on 5 HT1A receptors as an agonist in behavioral, biochemical and electrophysiological studies (10, 19, (23) (24) (25) (26) . In the light of these facts, the possibility exists that the agonist action of tandospirone on 5-HT1A receptors, but not benzodiazepine receptors, is related to its con flict effect.
There are several reports showing that two azapirones, buspirone and ipsapirone, act as partial agonists with agonist activity predomi nating on 5-HT1A receptors (27) (28) (29) . More over, Moser et al. (30) have reported that a compound which acts primarily as an antago nist on 5-HT1A receptors showed anticonflict action. Then, we studied the effect of 8-OH DPAT, a full agonist of 5-HT1A receptors, us ing this conflict test to determine which ac tion, agonist or antagonist action, is more im portant for producing the anticonflict effect. 8 OH-DPAT clearly produced strong anticon flict action. The minimum effective dose of 8 OH-DPAT in this test was nearly equal to that obtained by Engel et al. (31) in a mod ified Vogel's conflict test in rats. We have re ported that tandospirone inhibits forskolin stimulated adenylate cyclase in the rat hippo campus via 5-HT1A receptors (24) . In that study, we also found that the maximal inhibi tion by tandospirone was nearly equal to those by 8-OH-DPAT and 5-HT. This indicates that tandospirone is nearly a full agonist of 5-HT1A receptors. Moreover, we have found that spir operidol (a nonselective 5-HTIA antagonist), but not haloperidol (D2 antagonist) or ketan serin (5-HT2 antagonist), inhibits significantly the anticonflict action of tandospirone in Vogel's conflict test (H. Shimizu et al., unpub lished data). Therefore, these results suggest that the anticonflict effect of tandospirone in this model may result from its agonist action on 5-HT1A receptors.
In summary, we found that tandospirone showed anticonflict action in a modified Geller-Seifter conflict paradigm in rats with slightly lower minimum effective dose than di azepam, indicating its efficacy in the treatment of anxiety in humans. However, it was sug gested that the anticonflict action of tandospir one, unlike that of diazepam, was not medi ated by benzodiazepine receptors. Since a 5 HT1A selective agonist (8-OH-DPAT) also produced potent anticonflict action in this model, the possibility exists that the agonist action of tandospirone on 5-HT1A receptors, but not that on binzodiazepine receptors, is related to its conflict effect. Further studies on this point are in progress.
